Vis enkel innførsel

dc.contributor.authorShkolnikov, Vladimir M.
dc.contributor.authorKlimkin, Ilya
dc.contributor.authorMcKee, Martin
dc.contributor.authorJdanov, Dmitri A.
dc.contributor.authorAlustiza-Galarza, Ainhoa
dc.contributor.authorNémeth, László
dc.contributor.authorTimonin, Sergey A.
dc.contributor.authorNepomuceno, Marília R.
dc.contributor.authorAndreev, Evgeny M.
dc.contributor.authorLeon, David A.
dc.date.accessioned2022-11-22T14:05:55Z
dc.date.available2022-11-22T14:05:55Z
dc.date.issued2022-06-18
dc.description.abstractExcess mortality has been used to measure the impact of COVID-19 over time and across countries. But what baseline should be chosen? We propose two novel approaches: an alternative retrospective baseline derived from the lowest weekly death rates achieved in previous years and a within-year baseline based on the average of the 13 lowest weekly death rates within the same year. These baselines express normative levels of the lowest feasible target death rates. The excess death rates calculated from these baselines are not distorted by past mortality peaks and do not treat non-pandemic winter mortality excesses as inevitable. We obtained weekly series for 35 industrialized countries from the Human Mortality Database for 2000–2020. Observed, baseline and excess mortalities were measured by age-standardized death rates. We assessed weekly and annual excess death rates driven by the COVID-19 pandemic in 2020 and those related to seasonal respiratory infections in earlier years. There was a distinct geographic pattern with high excess death rates in Eastern Europe followed by parts of the UK, and countries of Southern and Western Europe. Some Asia-Pacific and Scandinavian countries experienced lower excess mortality. In 2020 and earlier years, the alternative retrospective and the within-year excess mortality figures were higher than estimates based on conventional metrics. While the latter were typically negative or close to zero in years without extraordinary epidemics, the alternative estimates were substantial. Cumulation of this "usual" excess over 2–3 years results in human losses comparable to those caused by COVID-19. Challenging the view that non-pandemic seasonal winter mortality is inevitable would focus attention on reducing premature mortality in many countries. As SARS-CoV-2 is unlikely to be the last respiratory pathogen with the potential to cause a pandemic, such measures would also strengthen global resilience in the face of similar threats in the future.en_US
dc.identifier.citationShkolnikov, Klimkin, McKee, Jdanov, Alustiza-Galarza, Németh, Timonin, Nepomuceno, Andreev, Leon. What should be the baseline when calculating excess mortality? New approaches suggest that we have underestimated the impact of the COVID-19 pandemic and previous winter peaks. SSM - Population Health. 2022;18en_US
dc.identifier.cristinIDFRIDAID 2053497
dc.identifier.doi10.1016/j.ssmph.2022.101118
dc.identifier.issn2352-8273
dc.identifier.urihttps://hdl.handle.net/10037/27474
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.journalSSM - Population Health
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titleWhat should be the baseline when calculating excess mortality? New approaches suggest that we have underestimated the impact of the COVID-19 pandemic and previous winter peaksen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution 4.0 International (CC BY 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution 4.0 International (CC BY 4.0)